Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Generic Injectables Market to Grow at Over 13% CAGR through 2025

Press release Description

Albany, New York, July 13, 2018: A new detailed study titled “Generic Injectables Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025” has recently been submitted to the repository of Market Research Reports Search Engine (MRRSE). According to the research report, the global generic injectables market is likely to grow at over 13% CAGR during the assessment period 2017-2025.

The business intelligence study offers in-depth analysis on the generic injectables market. According to the research study, growing demand for affordable medicines, increasing investment in research and development activities, and technological advancement in terms of injectables and dosage are among the key factors driving the growth of the generic injectables market during the assessment period.

In a bid to offer detailed insights and analysis to readers, the business intelligence study offers segment-wise forecast. The report segments the global generic injectables market into container type market, administration market, product market, administration market and region market. The container segment is further divided into vials, prefilled syringes, premixes, ampoules and others.

The administration segment is sub-segmented into infectious diseases, diabetes, oncology, cardiology, immunology and others. The product segment is bifurcated into large molecule injectables (biosimilars) and small molecule injectables, The large molecule injectables (biosimilars) are sub-divided into insulins, monoclonal antibodies (mAbs) ands others. The administration augment is categorized into intravenous, subcutaneous, intramuscular and others.

Geographically, the market is divided into key regions globally which are Europe, Latin America, Asia Pacific, North America, and Middle East & Africa. According to the research report, North America is one of the largest markets for generic injectables market. The demand for generic injectables in North America remains concentrated in the US, with Canada accounting for miniscule percentage of the market. In addition to North America, Asia Pacific is another lucrative market for generic injectables during the period of assessment period. The increasing emphasis on drug development and research and development is likely to provide an impetus to the growth of the market in the region.

The business intelligence study offers insights on the competitive landscape in the generic injectables market. The report profiles some of the leading players operating in the market. Some of these players are Pfizer Inc., Baxter, Mylan N.V., Hikma Pharmaceuticals PLC., Sanofi, Novartis AG (Sandoz International GmbH), Fresenius SE & Co. KGaA, Teva Pharmaceutical Industries Ltd., Lupin Ltd and Biocon. The players in the market are focusing on expansion, and mergers and acquisitions to consolidate their position in the market.

Browse Full Global Generic Injectables Market Report with TOC : https://www.mrrse.com/generic-injectables-market

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559
Email: sales@mrrse.com